全文获取类型
收费全文 | 5202篇 |
免费 | 286篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 63篇 |
儿科学 | 96篇 |
妇产科学 | 67篇 |
基础医学 | 760篇 |
口腔科学 | 162篇 |
临床医学 | 470篇 |
内科学 | 1203篇 |
皮肤病学 | 63篇 |
神经病学 | 462篇 |
特种医学 | 330篇 |
外科学 | 942篇 |
综合类 | 26篇 |
预防医学 | 239篇 |
眼科学 | 156篇 |
药学 | 192篇 |
中国医学 | 6篇 |
肿瘤学 | 278篇 |
出版年
2022年 | 45篇 |
2021年 | 96篇 |
2020年 | 64篇 |
2019年 | 74篇 |
2018年 | 100篇 |
2017年 | 64篇 |
2016年 | 81篇 |
2015年 | 96篇 |
2014年 | 141篇 |
2013年 | 194篇 |
2012年 | 244篇 |
2011年 | 242篇 |
2010年 | 144篇 |
2009年 | 135篇 |
2008年 | 262篇 |
2007年 | 209篇 |
2006年 | 229篇 |
2005年 | 261篇 |
2004年 | 210篇 |
2003年 | 221篇 |
2002年 | 248篇 |
2001年 | 156篇 |
2000年 | 152篇 |
1999年 | 166篇 |
1998年 | 63篇 |
1997年 | 53篇 |
1996年 | 42篇 |
1995年 | 33篇 |
1994年 | 40篇 |
1993年 | 38篇 |
1992年 | 79篇 |
1991年 | 75篇 |
1990年 | 62篇 |
1989年 | 55篇 |
1988年 | 63篇 |
1987年 | 63篇 |
1986年 | 56篇 |
1985年 | 51篇 |
1984年 | 37篇 |
1983年 | 29篇 |
1982年 | 26篇 |
1981年 | 29篇 |
1979年 | 39篇 |
1978年 | 28篇 |
1973年 | 23篇 |
1971年 | 25篇 |
1969年 | 25篇 |
1968年 | 26篇 |
1967年 | 25篇 |
1966年 | 24篇 |
排序方式: 共有5515条查询结果,搜索用时 15 毫秒
61.
Thomas Lehrnbecher Andreas Trusen Frank Deinlein Burkhard Hcht Alexander Marx Joachim Kühl 《Pediatric blood & cancer》2003,40(1):13-17
Lymphoproliferative disorder (LPD) is described in only a few children receiving chemotherapy for cancer. In all of them, an association between LPD and EBV (Epstein‐Barr Virus) was found. We report on a patient who developed LPD not associated with EBV while receiving chemotherapy for relapsed acute lymphoblastic leukemia (ALL). Despite discontinuation of chemotherapy, administration of intravenous immunoglobulins and surgery the patient died. Growing experience with this disorder may allow better treatment options in the future and will show whether LPD not associated with EBV requires different therapeutic strategies. Med Pediatr Oncol 2003;40:13–17, © 2003 Wiley‐Liss, Inc. 相似文献
62.
Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. 总被引:14,自引:0,他引:14
Philipp Str?bel Andrea Bauer Bernhard Puppe Til Kraushaar Axel Krein Klaus Toyka Ralf Gold Michael Semik Reinhard Kiefer Wilfred Nix Berthold Schalke Hans Konrad Müller-Hermelink Alexander Marx 《Journal of clinical oncology》2004,22(8):1501-1509
PURPOSE: Thymic epithelial tumors (TET) are rare epithelial neoplasms of the thymus with considerable histologic heterogeneity. This retrospective study focused on the correlation of WHO-defined TET histotypes with survival and tumor recurrence in a large cohort of patients receiving different modes of treatment. PATIENTS AND METHODS: Two hundred twenty-eight patients were followed for up to 21 years (median, 60 months; range, 1 to 252 months) after primary surgery. Forty-two patients received adjuvant radiotherapy (mean dose, 53 Gy), and 33 patients received adjuvant chemotherapy. RESULTS: Seventy-six (88%) of 86 patients with WHO type A, AB, and B1 thymomas were treated by surgery alone, with three tumor relapses after 3 to 10 years (median, 3.4 years). Twelve of 67 patients with WHO type B2 and B3 thymomas in Masaoka stages I and II were treated by adjuvant radiotherapy without evidence of tumor recurrence after 1 to 12 years (median, 4 years). Among 75 patients with B2 and B3 thymomas with incomplete resection or a tumor stage III or higher, the recurrence rate was 34% (n = 23) after 0.5 to 17 years (median, 5 years) in patients receiving adjuvant radiochemotherapy, compared to 78% (seven of nine patients) in patients without adjuvant radiochemotherapy. Incomplete tumor resection was associated with a high recurrence rate (65%) and a poor prognosis (P <.01). CONCLUSION: The long-term outcome of TET patients is related to tumor stage, WHO histotype, completeness of surgical removal, and type of treatment. Prospective trials are warranted to formally address the efficacy of adjuvant therapy in the treatment of localized and advanced malignant TETs. 相似文献
63.
64.
Zhang WJ Marx SK Laue C Hyder A Juergensen A Bickel M Schrezenmeir J 《Transplantation proceedings》2000,32(1):206-209
65.
66.
67.
Marx G Leuwer M Höltje M Bornscheuer A Herrmann H Mahr KH Vangerow B Heine J Piepenbrock S Rueckoldt H 《Acta anaesthesiologica Scandinavica》2000,44(4):410-416
BACKGROUND: Hepatic dysfunction is a common problem in patients after hemihepatectomy. Treatment with low-dose dopamine has been shown to be beneficial in hemihepatectomy patients. We hypothesized that dopexamine, a synthetic vasoactive catecholamine, due to its specific pharmocodynamic profile may be more effective in reducing hidden ischaemic episodes in the hepato-splanchnic region during and after temporary total cross-clamping of hepatic inflow in these patients. METHODS: The effects of low-dose dopexamine on hepatic venous haemoglobin oxygen saturation (ShvO2), hepatic venous lactate level, monoethylglycinxylid (MEGX) formation, hepatic synthetic function and indicators for hepatic cell damage were studied during hemihepatectomy and for 16 h postoperatively in hemihepatectomy patients and compared to those of low-dose dopamine. In a prospective, double-blind clinical study 20 patients received randomly either dopexamine (DPX) 0.5 microg kg(-1) min(-1) (n=10) or dopamine (DO) 2.5 microg kg(-1) min(-1) (n= 10). Infusions were started after induction of anaesthesia and continued 16 h postoperatively. Hepatic vein, radial and pulmonary artery were catheterized. Measurements were carried out after induction of anaesthesia, after total cross-clamping of hepatic inflow, and at 2 h and 16 h postoperatively. RESULTS: There were no differences in systemic haemodynamics, oxygenation, ShvO2, serum aminotransferases or MEGX levels between the groups. At 16 h postoperatively prothrombin and antithrombin III levels were significantly lower while hepatic venous lactate was significantly higher in the DPX group compared to the DO group. CONCLUSION: In patients undergoing hemihepatectomy, we could not reveal superior hepatoprotective effects of low-dose dopexamine compared to low-dose dopamine. 相似文献
68.
Preconditioning with short cycles improves ischemic tolerance in rat fast- and slow-twitch skeletal muscle 总被引:1,自引:0,他引:1
Mattei A Sutter PM Marx A Stierli P Heberer M Gürke L 《European surgical research. Europ?ische chirurgische Forschung. Recherches chirurgicales européennes》2000,32(5):297-304
AIM: The aim of this study was to investigate whether the efficacy of ischemic preconditioning (IP) in rat skeletal muscle depends on the duration of the preconditioning cycles. METHODS: Rats were divided into four groups (n = 10 each). The right hindlimb of rats in group A were subjected to 2.5 h of tourniquet ischemia followed by 2 h of reperfusion (I-R). Thereafter, muscular function was analyzed in vitro and high-energy phosphates (HEP) were determined by HPLC. Before I-R, right hindlimbs of rats in groups B-D subjected to IP with three cycles each consisting of 2.5, 5 or 10 min of ischemia followed by reperfusion for the same duration. RESULTS: Postischemic function of the extensor muscle was significantly improved with all three preconditioning protocols. Postischemic function of the soleus muscle was only improved by IP with three cycles of 5 min of ischemia and 5 min of reperfusion. Postischemic HEP tissue levels were not influenced by IP. CONCLUSION: This study shows for the first time that IP increases ischemic tolerance not only of fast-twitch but also of slow-twitch skeletal muscle. The efficacy of IP seems to be less dependent on the duration of the single preconditioning cycle than on the number of cycles performed. Three cycles each of 2.5, 5 or 10 min ischemia and reperfusion significantly improved postischemic skeletal muscle function. Tissue levels of HEPs, however, were not influenced by IP indicating that preservation of HEPs does not play a major role in the effects of IP on rodent skeletal muscle. 相似文献
69.
70.